Here was my response to someone a week ago that wa

Quote:

---

Why should we listen to you when you don't know shit about biotech. You're pumping $GLSI when you obviously cannot read the 5 year results from their trial. Do you fear that $CYDY in mTNBC will crush $GLSI ? No fear of that their own results will crush them.

The patients that did have a response to their drug had a 24.2% recurrence rate with a median time to recurrence of 99 days. The ones that didn't have a response had a 12.5% recurrence rate with a median time to recurrence of 438 days.

Almost twice as likely to have recurrence with their drug and have that recurrence four times sooner. I know the CEO is trying to spin this as a positive but that's simply laughable.

Cytodyn might have had missteps but unlike GLSI they have a stellar drug that will change the pharmaceutical landscape.
https://finance.yahoo.com/news/greenwich-life...00820.html

---